The drug for preventing and treating colds and flu :: Consumers survey results of for 1 quarter of 2010

Consumers survey results of for 1 quarter of 2010 in category

Antiviral medications / The drug for preventing and treating colds and flu

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Amizon (Farmak)	44.00%	5

2.	3	Грип-Хеель (Heel)	36.00%	4.09

3.	1	Arbidol (OTC-Фарм)	32.00%	3.64

4.		Ехінацея-Фаркос (Фаркос)	20.00%	2.27

5.		Афлубін (Perrigo)	16.00%	1.82

6.	2	Антигрипін (Національна гомеопатична спілка)	12.00%	1.36

6.	2	Гербіон Ехінацея (KRKA)	12.00%	1.36

8.	3	Influcid (DHU)	8.00%	0.91

8.	~	Кагоцел (Ніармедик Плюс)	8.00%	0.91

8.	4	Краплі від грипу др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	8.00%	0.91

11.	~	Ремавір (Олайнфарм)	4.00%	0.45

–.	3	Ремантадин-КР (Red star)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2010, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.